The Board of RMS acknowledges the press release announced today by the British High Commission regarding its Anglo-Indian partnership to distribute its MHRA approved Pro-Larva mask in India:
The Board of RMS acknowledges the press release announced today by the British High Commission regarding its Anglo-Indian partnership to distribute its MHRA approved Pro-Larva mask in India:
The Company is pleased to announce that all the resolutions that were put to shareholder at the Company’s annual general meeting (“AGM”) earlier today were passed. The votes cast for
Antony Legge, Executive Chairman of RMS, will make the following statement at today’s annual general meeting:
The Company has today placed on its website a list of questions from shareholders together with answers.
The Company is pleased to announce that the 5-ply version of its Pro-Larva anti-viral mask, developed with Volz Filters UK Ltd (“Volz”), has been approved by the UK’s Medicines and
New Pro-Larva mask incorporates unique British copper nanoparticle technology to create a virucidal barrier effective against Covid-19 and other viruses, including influenza
Finally, we got the opportunity to speak with Antony about today company update and ask a few questions we hope shareholders find informative. What is cleary stated, P2F’s company portfolio
The Company is pleased to report the significant progress achieved since the announcement on 18 February.
The Company announces that the results of the general meeting held today at BioCity, Nottingham were as follows:
Remoted Monitored Systems Plc reports that two of the engineers from the Lemu Group (“Lemu”), the manufacturers of the mask manufacturing machine, who are currently working on commissioning the Company’s
Remote Monitored Systems plc (“RMS” or the “Company”) notes that a shareholder circular (the “Circular”) convening a general meeting of the Company (the “General Meeting”) has been posted to shareholders